Skin and Connective Tissue Diseases
14
1
3
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
21%
3 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects
A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)
Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
Time To Efficacy and Onset Of Action Of Linezolid